Product details
Background:Urtoxazumab (TMA-15) is a humanizedized monoclonal antibody against Shiga toxin (Stx) 2.
• Shiga Toxin (Stx) Classification, Structure, and Function., PMID:25530917
• Shiga-toxin-converting bacteriophages., PMID:11686382
• Escherichia albertii Pathogenesis., PMID:32588811
• Shiga Toxin-Producing Escherichia coli Infections during Pregnancy., PMID:30360505
• Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing Escherichia coli (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice., PMID:33467588
• Targeting bacterial toxins., PMID:22441768
• Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview., PMID:31150744
• L-Arabinose inhibits Shiga toxin type 2-converting bacteriophage induction in Escherichia coli O157:H7., PMID:37332116
• Shiga toxin 2a and Enteroaggregative Escherichia coli–a deadly combination., PMID:26039753
• Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model., PMID:36977098






